Objectives: To provide current data for policy discussions and to assess future needs among newborn screening programs regarding the storage and use of residual dried blood spots (DBS) in the United States.

Study Design: An electronic questionnaire was administered to U.S. state health department laboratory directors in 2003.

Results: Responses were received from 49 of the 50 states. Approximately half of them stored residual DBS for more than 6 months, 57% did not have a written policy that determines how residual DBS can or cannot be used, and 16% informed parents that DBS might be retained. Residual DBS were used by 74% of respondents for evaluation of newborn screening tests, by 52% for clinical or forensic testing, and by 28% for epidemiologic studies. Use of DBS was reported more frequently by states with extended storage. When asked if they might participate in an anonymous multistate epidemiologic study by contributing unlinked DBS, 41% responded affirmatively.

Conclusions: More states have used residual DBS for evaluating newborn screening tests than for epidemiologic studies. There is potential interest among states in using unlinked DBS for multistate studies and a need for written policies addressing all uses of residual DBS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2005.12.053DOI Listing

Publication Analysis

Top Keywords

residual dbs
20
newborn screening
16
dbs
10
storage residual
8
residual dried
8
dried blood
8
blood spots
8
screening programs
8
screening tests
8
epidemiologic studies
8

Similar Publications

N-Acetyltyrosine as a Biomarker of Parenteral Nutrition Administration in First-Tier Newborn Screening Assays.

Int J Neonatal Screen

December 2024

Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, S110-3, Atlanta, GA 30341, USA.

Parenteral nutrition (PN) is a nutrient solution administered intravenously (IV) to premature babies. PN causes elevations of some amino acids in blood samples that are also biomarkers used in newborn screening (NBS). Therefore, PN status must be annotated by clinicians on dried blood spot (DBS) cards to reduce NBS laboratory burdens associated with potential false results; however, NBS laboratories continue to receive DBSs with misannotated PN status.

View Article and Find Full Text PDF

Steroid hormone concentrations in dried blood spots: A comparison between capillary and venous blood samples.

Clin Chim Acta

February 2025

Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Location University of Amsterdam, Amsterdam Gastroenterology Endocrinology & Metabolism, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam Gastroenterology Endocrinology & Metabolism, De Boelelaan 1117, Amsterdam 1081 HV, the Netherlands; Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Location University of Amsterdam, Amsterdam Reproduction & Development, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam Reproduction & Development, De Boelelaan 1117, Amsterdam 1081 HV, the Netherlands. Electronic address:

Background: An important aspect of the shift towards dried blood spots (DBS) as a sample matrix for laboratory measurements, is the availability of robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods that can reliably quantify analyte concentrations in DBS. The development and validation of these LC-MS/MS methods, however, concerns an extensive process, for which large amounts of DBS samples are required. DBS are usually obtained from capillary blood samples, but they can also be prepared from venous (residual) blood samples, which are widely available in clinical laboratories.

View Article and Find Full Text PDF

A spinal cord injury (SCI) disrupts the neuronal projections from the brain to the region of the spinal cord that produces walking, leading to various degrees of paralysis. Here, we aimed to identify brain regions that steer the recovery of walking after incomplete SCI and that could be targeted to augment this recovery. To uncover these regions, we constructed a space-time brain-wide atlas of transcriptionally active and spinal cord-projecting neurons underlying the recovery of walking after incomplete SCI.

View Article and Find Full Text PDF

Objective: To present a novel method for removing stimulus transient that exploits the absolute refractory period of electrically excitable neural tissues.

Background: Electrical stimulation often generates significant signal artifacts that can obscure important physiological signals. Removal of the artifact and understanding latent information from these signals could provide objective measures of circuit engagement, potentially driving advancements in neuromodulation research and therapies.

View Article and Find Full Text PDF

Background Neuromuscular blocking agents are crucial for anesthesia but can cause reversible paralysis, leading to risks like postoperative residual dysfunction. Undetected paralysis in the post-anesthesia care unit (PACU) jeopardizes patient safety by impairing airway function and increasing complications. Effective reversal, assessed clinically or via nerve stimulation, is critical to prevent residual postoperative curarization (RPOC), which is linked to significant morbidity and mortality.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!